Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Peter Friedmann to Substance Abuse, Intravenous

This is a "connection" page, showing publications Peter Friedmann has written about Substance Abuse, Intravenous.

 
Connection Strength
 
 
 
1.951
 
  1. Stein MD, Anderson B, Charuvastra A, Maksad J, Friedmann PD. A brief intervention for hazardous drinkers in a needle exchange program. J Subst Abuse Treat. 2002 Jan; 22(1):23-31.
    View in: PubMed
    Score: 0.260
  2. McGarry KA, Stein MD, Clarke JG, Friedmann PD. Utilization of preventive health services by HIV-seronegative injection drug users. J Addict Dis. 2002; 21(2):93-102.
    View in: PubMed
    Score: 0.260
  3. Stein MD, Friedmann P. Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance. Am J Addict. 2002; 11(4):262-70.
    View in: PubMed
    Score: 0.260
  4. Stein MD, Anderson B, Charuvastra A, Friedmann PD. Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange. Alcohol Clin Exp Res. 2001 Oct; 25(10):1487-93.
    View in: PubMed
    Score: 0.255
  5. Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001 Sep 1; 64(1):47-53.
    View in: PubMed
    Score: 0.254
  6. Charuvastra A, Anderson BJ, Friedmann PD, Stein MD. Perceived addiction treatment needs among alcohol using injection drug users. J Addict Dis. 2002; 21(4):93-107.
    View in: PubMed
    Score: 0.065
  7. Des Jarlais DC, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, Torian L, Glebatis D, Murrill C, Monterroso E, Friedman SR. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000 Mar; 90(3):352-9.
    View in: PubMed
    Score: 0.057
  8. Salomon N, Perlman DC, Friedmann P, Ziluck V, Des Jarlais DC. Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. Int J Tuberc Lung Dis. 2000 Jan; 4(1):47-54.
    View in: PubMed
    Score: 0.057
  9. Salomon N, Perlman DC, Friedmann P, Perkins MP, Ziluck V, Jarlais DC, Paone D. Knowledge of tuberculosis among drug users. Relationship to return rates for tuberculosis screening at a syringe exchange. J Subst Abuse Treat. 1999 Apr; 16(3):229-35.
    View in: PubMed
    Score: 0.054
  10. Des Jarlais DC, Vanichseni S, Marmor M, Buavirat A, Titus S, Raktham S, Friedmann P, Kitayaporn D, Wolfe H, Friedman SR, Mastro TD. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 15; 16(5):393-9.
    View in: PubMed
    Score: 0.049
  11. Des Jarlais DC, Friedmann P, Hagan H, Friedman SR. The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use. Am J Public Health. 1996 Dec; 86(12):1780-5.
    View in: PubMed
    Score: 0.046
  12. Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, O'Brien CP. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. N Engl J Med. 2016 Mar 31; 374(13):1232-42.
    View in: PubMed
    Score: 0.044
  13. Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995 Oct 18; 274(15):1226-31.
    View in: PubMed
    Score: 0.042
  14. Des Jarlais DC, Friedman SR, Friedmann P, Wenston J, Sotheran JL, Choopanya K, Vanichseni S, Raktham S, Goldberg D, Frischer M, et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS. 1995 Jun; 9(6):611-7.
    View in: PubMed
    Score: 0.041
  15. Lima ES, Friedman SR, Bastos FI, Telles PR, Friedmann P, Ward TP, des Jarlais DC. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction. 1994 Jun; 89(6):689-98.
    View in: PubMed
    Score: 0.038
  16. Des Jarlais DC, Choopanya K, Vanichseni S, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. Am J Public Health. 1994 Mar; 84(3):452-5.
    View in: PubMed
    Score: 0.038
  17. Vanichseni S, Des Jarlais DC, Choopanya K, Friedmann P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS. 1993 Jun; 7(6):887-91.
    View in: PubMed
    Score: 0.036
  18. Vanichseni S, Choopanya K, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 1992; 5(11):1119-23.
    View in: PubMed
    Score: 0.032
  19. Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991 Dec; 5(12):1509-13.
    View in: PubMed
    Score: 0.032
  20. Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991 Sep; 81(9):1185-91.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.